Compare AVXL & CLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVXL | CLW |
|---|---|---|
| Founded | 2004 | 1926 |
| Country | United States | United States |
| Employees | N/A | 3710 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 289.1M | 234.5M |
| IPO Year | 2013 | 2008 |
| Metric | AVXL | CLW |
|---|---|---|
| Price | $3.16 | $13.86 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $22.00 | $20.33 |
| AVG Volume (30 Days) | ★ 852.5K | 181.3K |
| Earning Date | 05-08-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,555,400,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.16 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 12.42 |
| 52 Week Low | $2.61 | $11.73 |
| 52 Week High | $13.99 | $30.96 |
| Indicator | AVXL | CLW |
|---|---|---|
| Relative Strength Index (RSI) | 40.94 | 46.62 |
| Support Level | $2.93 | $12.09 |
| Resistance Level | $3.76 | $18.85 |
| Average True Range (ATR) | 0.19 | 0.79 |
| MACD | 0.01 | -0.07 |
| Stochastic Oscillator | 12.23 | 54.88 |
Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.
Clearwater Paper Corp is engaged in the manufacturing and supplier of Solid Bleached Sulfate (SBS) paperboard packaging products. The company products includes: SBS paperboard which is a premium paperboard grade that is frequently used to produce folding cartons, food service, commercial printing items. It generates maximum revenue from Pulp and Paperboard segment. Company operate in United States and have globalized access too. Geographically, it derives maximum revenue from the United States.